Edition:
United Kingdom

People: Prothena Corporation PLC (PRTA.OQ)

PRTA.OQ on NASDAQ Stock Exchange Global Select Market

9.93USD
5:08pm BST
Change (% chg)

$0.35 (+3.65%)
Prev Close
$9.58
Open
$9.70
Day's High
$10.01
Day's Low
$9.66
Volume
12,624
Avg. Vol
112,390
52-wk High
$15.91
52-wk Low
$8.66

Collier, Richard 

Mr. Richard T. Collier is Independent Director of Prothena Corporation plc., since December 2012. He is the former Executive Vice President and General Counsel of Elan Corporation, plc (a pharmaceutical company), a position he held from 2004 to 2010. Prior to that, he served as Senior Vice President and General Counsel of Rhone-Poulenc Rorer Inc., Pharmacia & Upjohn Company and Pharmacia Corporation (all pharmaceutical companies). Mr. Collier was an Adjunct Professor of Law at the Temple University Beasley School of Law, where he taught drug and medical device law from 2004 to 2017. He also practiced law at two leading Philadelphia-based law firms and with the U.S. Federal Trade Commission and U.S. Department of Justice. Mr. Collier earned both his B.A. and his J.D. (law degree) from Temple University. He has served on our Board since 2012.

Basic Compensation

Total Annual Compensation, USD 73,933
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 435,067
Fiscal Year Total, USD 509,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lars Ekman

526,938

Gene Kinney

5,148,240

Tran Nguyen

3,260,720

Karin Walker

--

Wagner Zago

--

Arthur Homan

2,479,620
As Of  31 Dec 2017